ask="15.44"
ask_size="2900"
average_daily_volume="37005"
bid="N/A"
bid_size="N/A"
book_value="5.83"
change="-0.80"
change_from_200_day_moving_average="-4.34"
change_from_50_day_moving_average="-4.39"
change_from_52_week_high="-11.57"
change_From_52_week_low="4.77"
change_in_percent="-5.13%"
close="14.79"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-13.50"
ebitda="-25.94M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.61"
eps_estimate_next_year="-2.23"
ex_dividend_date="N/A"
float_shares="6895000"
high="15.72"
high_52_weeks="26.36"
last_trade_date="2/14/2017"
last_trade_price="14.79"
last_trade_size="1515"
last_trade_time="4:00pm"
low="14.58"
low_52_weeks="10.02"
market_capitalization="247.20M"
moving_average_200_day="19.13"
moving_average_50_day="19.18"
name="Protagonist Therapeutics
Inc."
notes="N/A"
one_year_target_price="31.00"
open="15.52"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-22.69%"
percent_change_from_50_day_moving_average="-22.87%"
percent_change_from_52_week_high="-43.89%"
percent_change_from_52_week_low="+47.60%"
previous_close="15.59"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.67"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16714000"
short_ratio="7.43"
stock_exchange="NGM"
symbol="PTGX"
volume="22174"
weeks_range_52="10.02 - 26.36"
